301246 宏源药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-0.0251.1802.69322.93334.508
总资产报酬率 ROA (%)-0.0190.8971.83013.78623.607
投入资产回报率 ROIC (%)-0.0211.0122.14417.43629.964

边际利润分析
销售毛利率 (%)12.71212.18512.98723.32433.635
营业利润率 (%)0.5013.3915.14123.25634.758
息税前利润/营业总收入 (%)0.8773.2034.63122.63034.808
净利润/营业总收入 (%)-0.1482.9064.24221.06931.299

收益指标分析
经营活动净收益/利润总额(%)466.50497.24290.91266.07865.527
价值变动净收益/利润总额(%)5.97511.51022.60635.56734.909
营业外收支净额/利润总额(%)-27.085-0.593-7.190-0.410-0.622

偿债能力分析
流动比率 (X)2.9132.6823.5001.2611.667
速动比率 (X)2.6462.4443.2910.9941.044
资产负债率 (%)26.53325.13022.84545.45331.011
带息债务/全部投入资本 (%)16.42712.84311.75428.0927.396
股东权益/带息债务 (%)497.409663.789733.974244.4231,188.820
股东权益/负债合计 (%)276.866297.906337.728120.007222.464
利息保障倍数 (X)1.819-19.111-28.042-42.601131.159

营运能力分析
应收账款周转天数 (天)55.07745.43945.92839.14327.248
存货周转天数 (天)65.52953.48554.81083.884125.130